We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

February 26, 2021

“These are interventions that actually work” Brian Dolan

Reports
Ian Matthews
&

This month’s Digital Health Videocast sees us sit down with Brian Dolan, Founder and lead writer of Exits & Outcomes (E&O), following the highly successful launch of our latest industry report Prescription Digital Therapeutics (PDT) The Future of Digital Therapeuticsco-created by HealthXL and E&O.


For those of you following our videocast series, there may be a sense of déjà vu as we learn of Brian’s early career connection with Washington DC (much like our previous sit-downs with Sarah Iselin, Chris Coburn and Steve Kraus). Having attended Boston University and taking advantage of their excellent journalism school Brian was to find himself placed in Washington DC as a political correspondent for a semester. A career as a political journalist was not on the cards but Washington had captivated him. On graduating from Boston University Brian moved to the nation’s capital permanently as an editor for the media brand Fierce Markets. It was during his tenure here in which he was exposed to both technology and healthcare publications, helping to launch a series of publications focused on mobile in the mid-2000s. 


We learn of his passion as he watched the mobile industry evolve out of nothing, indeed an industry that would be paramount to the evolution of healthcare. On seeing mobile solutions being adopted across industries Brian felt there was ample opportunity to integrate it with the healthcare industry who had not fully embraced it yet and so in 2008 MobiHealthNews was born as a health tech publication.


Brian’s understanding of the fusion and possibilities between technology and healthcare has evolved over the past decade as the industry moved from the early days of med-tech to what we know now as digital health. 


Digital health has come to mean so many things” Brian tells us and it is perhaps for this reason he founded Exits & Outcomes in 2019. “Digital health has matured considerably in the past 12 years since I first started writing about it, but most health tech journalism is still written for those just entering the discussion. Exits & Outcomes (E&O) is a subscription-only, weekly newsletter for digital health strategists, creatives, and operators.”


It is Brian's experience in this industry that makes him such a valuable collaborator on our latest industry report. HealthXL released our first industry report on Digital Therapeutics (DTx) back in 2018 but so much has changed since then. A wide variety of companies have co-opted the term “digital therapeutics'' to describe their digital health offerings. We discuss our collaboration on the report which seeks to cut through some of that noise by focusing on a smaller promising subset of this group: prescription digital therapeutics.


A key part of our conversation turns to how we may define DTx with Brian summing up “The key to it is (DTx) are not just interventions but they have some sort of evidence to back them up...These are interventions that actually work”.


During the videocast we dive into a number of areas including:


What does the future of DTx look like to you. ? Get in touch with us here!

HealthXL Executive members can access the report for free on the Community Hub. If you are not an Executive member yet, you can access an 11-page snapshot for free here.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Masterclass: The Regulation of DTx

15th June @ 10:30AM EDT

Join us in this Masterclass led by BlueBridge Technologies as we discuss the regulation of DTx. Great opportunity to listen, learn and most importantly, enjoy.

Featuring
Stephen Gibney
Stephen Gibney
Quality Director, BlueBridge Technologies
Featuring
Stephen Gibney
Stephen Gibney
Quality Director, BlueBridge Technologies
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Sprint: Digital Women's Health

16th June @ 10:30AM EDT

This series of 2 meetings discusses in detail with other thought leaders the main unmet needs/gaps in Women’s Health and the best routes to market and adoption strategies for Digital Health products in the space.

Featuring
Estefanía 'Nia' Escobar-Kölle
Estefanía 'Nia' Escobar-Kölle
Innovation Manager Life & Health Ventures, SCOR
Caoimhe Vallely-Gilroy
Caoimhe Vallely-Gilroy
Head of Digital Health & Therapeutics at Healthcare Business of Merck
Featuring
Estefanía 'Nia' Escobar-Kölle
Estefanía 'Nia' Escobar-Kölle
Innovation Manager Life & Health Ventures, SCOR
Caoimhe Vallely-Gilroy
Caoimhe Vallely-Gilroy
Head of Digital Health & Therapeutics at Healthcare Business of Merck
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

What are the best routes to market in DTx?

23rd June @ 10:30AM EDT

Join our Digital Health Meeting as we discuss the different routes to market and how they determine the success of a DTx product. This session is guaranteed to be filled with valuable insights, interesting debate and great conversation.

Featuring
Smit Patel
Smit Patel
Director of Digital Medicine at DiMe
Featuring
Smit Patel
Smit Patel
Director of Digital Medicine at DiMe
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Data Analytics for Precision Population Medicine

24th June @ 10:30AM EDT

Join our Digital Health Meeting focused on Data Analytics for Precision Population Medicine. Apply now to get involved in the conversation, network with peers and share your thoughts on the topic.

Featuring
Tai Chung
Tai Chung
Director of Partnerships, RQC, and Deputy General Counsel at Medullan
Featuring
Tai Chung
Tai Chung
Director of Partnerships, RQC, and Deputy General Counsel at Medullan

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Masterclass: The Regulation of DTx

15th June @ 10:30AM EDT

Join us in this Masterclass led by BlueBridge Technologies as we discuss the regulation of DTx. Great opportunity to listen, learn and most importantly, enjoy.

Featuring
Stephen Gibney
Stephen Gibney
Quality Director, BlueBridge Technologies
Featuring
Stephen Gibney
Stephen Gibney
Quality Director, BlueBridge Technologies
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Sprint: Digital Women's Health

16th June @ 10:30AM EDT

This series of 2 meetings discusses in detail with other thought leaders the main unmet needs/gaps in Women’s Health and the best routes to market and adoption strategies for Digital Health products in the space.

Featuring
Estefanía 'Nia' Escobar-Kölle
Estefanía 'Nia' Escobar-Kölle
Innovation Manager Life & Health Ventures, SCOR
Caoimhe Vallely-Gilroy
Caoimhe Vallely-Gilroy
Head of Digital Health & Therapeutics at Healthcare Business of Merck
Featuring
Estefanía 'Nia' Escobar-Kölle
Estefanía 'Nia' Escobar-Kölle
Innovation Manager Life & Health Ventures, SCOR
Caoimhe Vallely-Gilroy
Caoimhe Vallely-Gilroy
Head of Digital Health & Therapeutics at Healthcare Business of Merck
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

Primary Care: the Front Door for Virtual Care Delivery

16th June @ 11:30AM EDT

Join our Digital Health Meeting focused on Primary Care: the Front Door for Virtual Care Delivery. Apply now to get involved in the conversation, network with peers and share your insights on this topic.

Featuring
Mazin Alsaffar
Mazin Alsaffar
Academic Research Lead, Babylon Health
Featuring
Mazin Alsaffar
Mazin Alsaffar
Academic Research Lead, Babylon Health
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support

Masterclass: How can pharma use digital education to engage HCPs?

17th June @ 10:30AM EDT

Join us in this masterclass led by Figure1 to learn more about how pharma can use digital education to engage HCPs. Apply promptly to hear valuable insights from thought leaders in this space.

Featuring
Joshua Landy MD
Joshua Landy MD
Chief Medical Officer, Figure 1
Featuring
Joshua Landy MD
Joshua Landy MD
Chief Medical Officer, Figure 1

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.